Search Results for 'amyris'

Amyris & CJ CheilJedang Corporation partner to expand farnese to Asia

Amyris & CJ CheilJedang Corporation partner to expand farnese to Asia

May 22, 2016 |

In California, Amyris and CJ CheilJedang Corporation have signed a Memorandum of Understanding to support large-scale manufacturing of Amyris’s farnesene in existing CJ facilities. CJ is a leading producer of fermentation-based products such as feed amino acids, MSG, and nucleotides. The arrangement described in the MOU would enable Amyris to utilize CJ’s state of the […]

Read More

The Big Year Continues: The Digest’s 2016 8-Slide Guide to Amyris

The Big Year Continues: The Digest’s 2016 8-Slide Guide to Amyris

May 16, 2016 |

Amyris reported Q1 2016 net loss of $15,3M on revenues of 8.8 million, compared with $7.9 million for the first quarter of 2015. The increase from Q1 2015 included product sales growth of 50% over Q1 2015 driven by continued growth in the personal care business. Approximately 92% of Q1 2016 product sales related to […]

Read More

Amyris inks 5-year $100M+ biofene supply pact for nutraceutical market

Amyris inks 5-year $100M+ biofene supply pact for nutraceutical market

April 28, 2016 |

In California, the Eco-Emirs of Emeryville, Amyris executed a five year Biofene supply agreement with a global nutraceuticals company. Upping the ante from January This new, long-term agreement replaces the parties’ one-year purchase agreement, which was previously announced on January 4, 2016.  More on that deal here. Under the new supply agreement, the mystery customer […]

Read More

Demand for Amyris farnesene requires production expansion at Brotas plant

Demand for Amyris farnesene requires production expansion at Brotas plant

March 22, 2016 |

In Brazil, Amyris announced an expansion project to add a dedicated flavors & fragrances manufacturing unit to its Brotas industrial fermentation complex in Brazil. This planned expansion enables the company to meet demand for contracted flavors and fragrances molecules for its collaboration partners. The expansion provides for focused use of the current Brotas industrial fermentation […]

Read More

Amyris Biossance launches “The Refresher” biodegradable makeup removing cloths

Amyris Biossance launches “The Refresher” biodegradable makeup removing cloths

March 20, 2016 |

In California, Biossance has released its new Refresher Makeup Removing Cloths ─ marking the fourth product announced since brand launch in June 2015. Now available at biossance.com and HSN, The Refresher is a package of biodegradable cleansing cloths enriched with an all-natural antioxidant blend of ingredients that gently remove makeup and impurities without leaving skin […]

Read More

Amyris, REG, GFB, oil prices, infrastructure, incentives: 8 new episodes of BioChannelTV’s Faces, The New Voices

Amyris, REG, GFB, oil prices, infrastructure, incentives: 8 new episodes of BioChannelTV’s Faces, The New Voices

March 13, 2016 |

BioChannel.TV is streaming 5 new episodes of Faces, the one-to-one interview program, featuring REG CEO Dan Oh, Amyris CEO John Melo, Green Ox Pallets president Adam Pener, GF Biochemicals CCO Marcel van Berkel, and Netherlands Minister Economic Remco Zeeuw. And, three new episodes of The New Voices, the “why can’t a renewables policy program be […]

Read More

Is this the Amyris year, as management expects revenue to triple?

Is this the Amyris year, as management expects revenue to triple?

March 10, 2016 |

Despite a dismal beginning to earnings season, as Amyris, Arcadia disappoint, the Eco-Emirates of Emeryville look set for huge expansion in 2016. In California, Amyris reported Q4 revenues of $9.6mn and a net loss for Q4 of $41.9 million ($34 million after elimination of non-recurring items), well below Wall Street consensus estimates of $32.4 million. […]

Read More

The Big Year Dawns: The Digest’s 2016 8-Slide Guide to Amyris

The Big Year Dawns: The Digest’s 2016 8-Slide Guide to Amyris

March 10, 2016 |

In California, Amyris reported Q4 revenues of $9.6mn and a net loss for Q4 of $41.9 million ($34 million after elimination of non-recurring items), well below Wall Street consensus estkmates of $32.4 million. “The fourth quarter resulted in our best renewable product sales quarter to date during 2015 while also highlighting our challenge in completing […]

Read More

Amyris closes $20M private placement

Amyris closes $20M private placement

February 21, 2016 |

In California, Amyris closed a $20 million private placement of unsecured promissory notes to existing investors. In connection with this financing, the company also issued warrants for 2.9 million shares of common stock. The private placement was led by a long-term investor affiliated with one of Amyris’s board members, John Doerr, of the venture capital […]

Read More

Amyris debuts Pathways Program: access to its synthetic biology technology.

Amyris debuts Pathways Program: access to its synthetic biology technology.

January 17, 2016 |

In California, Amyris announced the availability of its Pathways Program, a program that provides partners a low-cost, low-risk opportunity to access Amyris’s industry-leading synthetic biology technology. Through the Pathways Program, partners can, with a small initial investment, sponsor and secure a molecule they are interested in having Amyris produce using the next-generation tools and technologies […]

Read More